SSY Group (HK:2005) has released an update.
SSY Group has announced an upward revision of the annual cap for their continuing transactions with Sichuan Kelun under the Master Sale and Purchase Agreement, due to surging demand for Material B, a pharmaceutical material. This revision is necessary to accommodate increasing sales projections for the year ending December 31, 2024, and to ensure that the needs of the Group are met. The revision falls within regulatory guidelines, requiring only reporting, announcement, and annual review, but not independent shareholder approval.
For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.
